???global.info.a_carregar???
Sara Hummeid a Ph.D. candidate in Pharmaceutical Chemistry and Therapeutics at the Faculty of Pharmacy, at the University of Lisbon. Sara completed her Integrated Master's Degree in Pharmaceutical Sciences in 2019, at the Faculty of Health Sciences of the University of Beira Interior (UBI). Sara started her research work at The Health Sciences Research Centre (CICS) at UBI in the fifth year of her degree. Sara collaborated on a project to develop new proteasome inhibitors for cancer therapy which was the subject of her master thesis. Throughout her research experience, Sara developed skills in medicinal and organic chemistry, analytical chemistry, stability studies, cell-based assays, and enzymatic assays. Furthermore, Sara has had an internship in 2018 at St Bartholomew's Hospital - Barts Health NHS Trust, London, UK.
Read full resume ↓
Identification

Personal identification

Full name
Sara Hummeid

Citation names

  • Hummeid, Sara

Author identifiers

Ciência ID
A81A-D0B7-90DA
ORCID iD
0000-0003-1801-5473

Addresses

  • Avenida Professor Gama Pinto, Lisbon , 1649-003, Lisbon, Lisbon, Portugal (Professional)

Languages

Language Speaking Reading Writing Listening Peer-review
Arab (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Portuguese Advanced (C1) Proficiency (C2) Advanced (C1) Proficiency (C2) Advanced (C1)
Turkish Elementary (A2) Elementary (A2) Beginner (A1) Intermediate (B1) Beginner (A1)
Spanish; Castilian Beginner (A1) Intermediate (B1) Beginner (A1) Intermediate (B1) Beginner (A1)
Education
Degree Classification
2020/10/01 - 2024
Ongoing
 Phd degree in Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2019/07/16
Concluded
 Ciências Farmacêuticas (Mestrado)
Major in Sem especialização
Universidade da Beira Interior, Portugal
"Synthesis and evaluation of 5-substituted (thio)barbiturates as proteasome inhibitors for cancer therapy. Experiência Profissionalizante na vertente de Farmácia Comunitária, Hospitalar e Investigação" (THESIS/DISSERTATION)
 15
2011/09/01 - 2013/02/28
Attended
 Pharmacy (Bachelor)
Major in Pharmacy
Damascus University, Syria
 90%
Affiliation

Science

Category
Host institution 		Employer
2018/01/22 - 2019/09/30 Research Trainee (Research) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal

Others

Category
Host institution 		Employer
2018/06/01 - 2018/08/31 Clinical Pharmacist Trainee St Bartholomew's Hospital, Barts Health NHS trust., United Kingdom
St Bartholomew's Hospital, United Kingdom
2018/01/09 - 2018/04/13 Pharmacist Trainee Holon Covilha pharmacy, Portugal
2016/08/01 - 2016/09/01 Pharmacist Trainee Bial , Portugal
Projects

Other

Designation Funders
2023/01 - Current OncoIRONTools. Ferrous Iron-Activable Drug Conjugates: Targeting Iron Metabolism in the Era of Precision Oncology
2022.07857.PTDC
PhD Student Fellow
Ongoing
Outputs

Publications

Conference poster
  1. Hummeid S.; Carrasco M. P.; Remón P.; Pischel U.; Moreira R.. "Development of azobenzene photoswitches with potential as VEGFR2 inhibitors". Paper presented in Colégio de Química 5th Meeting and Summer School 2022, 2022.
  2. Hummeid S.; Carrasco M. P.; Remón P.; Pischel U.; Moreira R.. "Potential VEGFR2 photoswitchable inhibitors: Design, synthesis and photochemical characterization". Paper presented in iMed.ULisboa Meeting 2022, 2022.
  3. Hummeid S.; Carrasco M. P; Remón P.; Pischel U.; Moreira R.. "Design and synthesis of azobenzene photoswitches with potential as VEGFR2 inhibitors". Paper presented in 14ENQO & 7ENQT 2022, 2022.
  4. Hummeid, Sara. "Synthesis of 5-benzyldene(thio)barbiturates with potential proteasomal inhibition for cancer therapy". Paper presented in IV Annual Scientific Congress of UBIPharma, 2018.
Thesis / Dissertation
  1. Hummeid, Sara. "Synthesis and evaluation of 5-substituted (thio)barbiturates as proteasome inhibitors for cancer therapy". Master, 2019. http://hdl.handle.net/10400.6/8913.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2020/01/15 5-Substituted (thio)barbiturates as proteasome inhibitors for cancer therapy: design, synthesis and biological evaluation The 13th National Organic Chemistry Meeting and the 6th National Medicinal Chemistry Meeting
Portuguese Chemical Society (SPQ) (Aveiro, Portugal)
2019/11/15 Proteasome inhibition of synthetic 5-substituted (thio)barbiturates III International Congress in Health Sciences Research Towards Innovation and Entrepreneurship: Trends in Aging and Cancer
CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade de Beira Interior (Covilha, Portugal)
2019/07/05 Synthesis and evaluation of 5-substituted (thio)barbiturates as proteasomal inhibitors for cancer therapy XIV ANNUAL CICS-UBI SYMPOSIUM 2019 UBI, Covilhã, Portugal
CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade de Beira Interior (Covilha, Portugal)

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2017/11/09 - 2017/11/11 Was part of the volunteering team assisting in the Champalimaud Research Symposium 2017, held between 9-11 of October 2017, in Lisbon, Portugal
Symposium
 Champalimaud Research Symposium 2017
Centro Champalimaud, Portugal